First Line gastroeSOphageal metastatiC canceR primAry and disTant (if Oligometastatic) lEsions-directed Radiotherapy, a Multicentric, Phase III, Randomized Controlled Trial
Clinical trial NCT06922279 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06922279
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-30
- Primary completion
- 2029-10-30
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.